SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

2 Oct 2017 07:32

RNS Number : 3676S
Numis Corporation PLC
02 October 2017
 

2nd October 2017

Numis Corporation Plc

Trading Update

 

Monday 2nd October 2017 at 7.00am: Numis Corporation Plc ("Numis") today issued a trading update relating to the year ended 30th September 2017.

 

Our second half trading performance was very strong and recorded revenue 47% higher than the first half of 2017 and 38% higher than the second half of 2016. Consequently, full year revenue has grown by 15% versus prior year, and it is anticipated that profit will show similar levels of growth.

 

Our Corporate Broking & Advisory business ("CB&A") completed 98 transactions in total (2016: 86) which included equity fund raises totalling £2.5 billion, up 38% on prior year (2016: £1.8 billion). Revenue from CB&A activities has grown by 15% versus prior year.

 

Our Equities business performed well. Against a background of generally positive equity markets, combined institutional commission and trading revenues increased by 15% year-on-year. We continue to work closely with our institutional clients and believe the firm is well positioned as the implementation of MiFID II draws closer.

 

Numis will announce full preliminary results for the year ended 30th September 2017 on Wednesday 6th December 2017.

 

 

Alex Ham and Ross Mitchinson, Co-Chief Executive Officers, said:

 

"We are pleased to report that the second half was our best on record in terms of both revenue and operating profit. In addition, we have increased our focus on supporting unquoted companies and playing a key role in developing the capital markets which support them.

 

Our deal pipeline is strong and we remain determined to support ambitious companies of all sizes seeking capital and high quality advice to grow, whilst simultaneously investing in our people, platform and relationships. Whilst we cannot predict the direction of the market or the health of the equity issuance environment, there is good momentum in the business and we look forward to the future with confidence."

 

ENDS

 

 

Contacts

Numis Corporation:

Alex Ham & Ross Mitchinson 020 7260 1245

Co-Chief Executive Officers

 

 Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Samantha Harrison 020 77865 2411Harrison J Clarke 020 7184 4384 

 

 

 

 

 

 

Notes for Editors

Numis is a leading independent corporate advisory and stockbroking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUUNRBKARRRA
Date   Source Headline
23rd Jan 20171:00 pmRNSDirectors' Dealing
19th Jan 20172:00 pmRNSDirectors' Dealing
18th Jan 201711:00 amRNSDirector's Dealing
12th Jan 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20179:51 amRNSAnnual Report and Annual General Meeting Notice
3rd Jan 201710:38 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20163:00 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 201611:05 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSPreliminary Results for the year ended 30 Sep 2016
1st Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20162:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20162:00 pmRNSDirector's Dealing
27th Oct 20161:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 201611:00 amRNSPurchase of shares in Close Period
3rd Oct 20167:00 amRNSTrading Update
14th Sep 20167:00 amRNSHolding(s) in Company
6th Sep 20169:45 amRNSDirector/PDMR Shareholding
5th Sep 20164:42 pmRNSGrant of Share Awards
22nd Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20163:11 pmRNSTransaction in Own Shares and Total Voting Rights
1st Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jul 201611:30 amRNSTransaction in Own Shares and Total Voting Rights
7th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20167:00 amRNSBoard Appointments
29th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
22nd Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 201611:47 amRNSDirector's Dealing
24th May 20163:16 pmRNSPosting of Interim Report
23rd May 20163:00 pmRNSHolding(s) in Company
19th May 20162:12 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 201610:00 amRNSTransfer of Shares from Treasury to EBT and TVR
13th May 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
9th May 20169:39 amRNSTransfer of Shares from Treasury to EBT and TVR
6th May 20167:01 amRNSBoard Changes
6th May 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.